Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Clinical trial NCT00889863 · COMPLETED

Trial details

NCT number: NCT00889863
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Juvenile Idiopathic Arthritis With Active Flare

Start date: 2009-07-01
Primary completion: 2011-09-01
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.